DRAP approves passive immunisation technique for treating COVID-19

Published: April 9, 2020
Drug regulatory authority. PHOTO: FILE

Drug regulatory authority. PHOTO: FILE

KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted approval for a passive immunisation technique to treat coronavirus patients along with approval for the local production of ventilators and the manufacturing of the pharma ingredients for chloroquine, a drug found effective against COVID-19.

The approval has been granted after the technical evaluation of the ventilators and successful clinical trials of the medicine.

Aga Khan University unveils CoronaCheck self-screening app

The federal government is likely to make the official announcement on Friday.

The National Institute of Blood Diseases (NIBD) had put forth the suggestion to the government of treating COVID-19 patients via passive immunisation.

Considering the recommendations, the Sindh government consulted experts at the Indus Hospital, Aga Khan University Hospital, including the Sindh Blood Transfusion Authority (SBTA), on the matter, who also favoured the technique.

Earlier, Punjab, as well as the Khyber Pakhtunkhwa (K-P) government, had issued a notification regarding the grant of approval for the technique, while the federal government had decided a protocol for treating and conducting a medical analysis of the aforementioned technique, which has also been approved by National Bioethics Committee (NBC).

As per sources in Islamabad, the protocol for collecting the data of the recovering patients has also been developed. After the approval, the coronavirus patients will be treated via the anti-bodies technique in NIBD Karachi, LUMS Medical University in Lahore and Liaquat University of Medical & Health Sciences (LUMHS) in Jamshoro.

The recovered patients, after the official announcement of the approval of the technique, will be obliged to donate their plasmas.

For the first time, after approval, ventilators would be produced locally which would save foreign exchange. Similarly, the pharma ingredients of chloroquine would also be manufactured locally in Pakistan after a decade.

Coronavirus crisis could plunge half a billion people into poverty: Oxfam

The authority is further deliberating on the recommendation of obliging recovered patients to donate their plasma.

The health department and medical experts are deliberating over, taking and preserving plasma of a coronavirus patient, and utilising it for treating a patient critically ill with COVID-19.

Medical experts have further recommended the federal government to store the information of the recovered patients in a database and provide them to the registered centres for conducting passive immunisation so that the process of collecting plasma from recovered patients could begin on a regular basis.

Facebook Conversations

Reader Comments (1)

  • israr
    Apr 9, 2020 - 2:05PM

    yes Pakistan go lead the fight against corona its all in us we are the medicine Allah made us the best medicine we will cure others with plasma with antibodies … may be same blood group can be considered (although plasma is not really red blood cells) still to avoid and carry on with first test go like for like A+ blood group for A+ patient pleaseRecommend

Leave Your Reply Below

Your comments may appear in The Express Tribune paper. For this reason we encourage you to provide your city. The Express Tribune does not bear any responsibility for user comments.

Comments are moderated and generally will be posted if they are on-topic and not abusive. For more information, please see our Comments FAQ.

More in Pakistan